Study of the Safety and Efficacy of CC-5013 Treatment For Patients With Myelodysplastic Syndrome
Clinical trial NCT00044382 · COMPLETED
Trial details
- NCT number
- NCT00044382
- Sponsor
- Celgene
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2002-02-01
- Primary completion
- 2007-01-01
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.